机器人挽救性淋巴结清扫术治疗复发性前列腺癌:68例经验与临床管理启示
本研究回顾性分析68例根治性前列腺切除术后淋巴结复发患者接受机器人挽救性淋巴结清扫术的围手术期与肿瘤学结局。中位手术时间126分钟,出血量50ml,住院4天,无Clavien 3级以上并发症。中位随访12.1个月,37%患者达完全生化缓解,中位至进一步治疗时间12.4个月。
要点
- 机器人挽救性淋巴结清扫术围手术期并发症低,无重大并发症。
- 37%患者术后达完全生化缓解(PSA<0.2 ng/ml),11%达不可测PSA。
- 术前PSMA PET/CT、较低术前PSA、较长根治至挽救手术间隔及完全生化缓解预示更长治疗-free生存。
核心结论
- 机器人挽救性淋巴结清扫术可行,围手术期并发症低,多数患者可延迟进一步系统治疗。
- PSMA PET/CT检测主要限于大于5mm的肿瘤病灶,可能遗漏小淋巴结转移。
研究设计与样本
- 单中心回顾性系列研究,纳入68例根治性前列腺切除术后淋巴结复发接受机器人挽救性淋巴结清扫术的患者。
- 分析围手术期数据、术后30天内并发症及肿瘤学结局(组织学、PSA变化、PSA最低值、至进一步治疗时间)。
- 采用Kaplan-Meier和Cox回归分析识别肿瘤学结局预测因素;对PET/CT与组织学阳性淋巴结数目不匹配者行PSMA免疫组化。
主要发现
- 中位手术时间126分钟,出血量50ml,住院时间4天,无Clavien 3级以上重大并发症。
- 中位随访12.1个月,中位至进一步治疗时间12.4个月。
- 37%患者达完全生化缓解(PSA<0.2 ng/ml),11%达不可测PSA,其中3例维持不可测超过1年。
- 较低术前PSA、较长根治至挽救手术间隔、术前PSMA PET/CT阳性及挽救术后完全生化缓解是更长治疗-free生存的显著预测因素(均p<0.005)。
- PSMA免疫组化显示PSMA PET/CT倾向于遗漏小于5mm的小淋巴结转移。
临床怎么用
- 对于根治性前列腺切除术后淋巴结复发患者,机器人挽救性淋巴结清扫术可作为低并发症的救援选择,延迟系统治疗。
- 术前PSMA PET/CT阳性、较低PSA及较长无治疗间隔者可能更获益,术后完全生化缓解提示更好治疗-free生存。
局限性
- 单中心回顾性设计,样本量68例,中位随访仅12.1个月,结论需更长期随访验证。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
PURPOSE: Salvage lymph node dissection is a rescue treatment for patients with nodal recurrence after radical prostatectomy. Very limited data are available on robotic salvage lymph node dissection. Our purpose was to investigate perioperative and oncological outcomes of robotic salvage lymph node dissection in a large monocentric series. MATERIALS AND METHODS: Perioperative data, complications within 30 days after surgery and oncological outcomes as assessed by histology, prostate specific antigen changes, prostate specific antigen nadir after salvage lymph node dissection, and time to further therapy were analyzed. To identify predictive factors for oncological outcome, Kaplan-Meier and Cox-regression analyses were performed. For cases with a mismatch between preoperative positron emission tomography/computed tomography and the number of histologically positive lymph nodes, prostate specific membrane antigen immunohistochemistry was performed on removed lymph nodes. RESULTS: A total of 68 patients underwent robotic salvage lymph node dissection with a median operation time of 126 minutes, a blood loss of 50 ml, and a length of stay of 4 days. No major complications (>Clavien 3) occurred. Median followup was 12.1 months. Median time to further therapy was 12.4 months, 37% of patients experienced complete biochemical response (prostate specific antigen <0.2 ng/ml) and 11% reached an undetectable prostate specific antigen, which was maintained for >1 year in 3 cases. Lower preoperative prostate specific antigen, longer time between radical prostatectomy and salvage lymph node dissection, preoperative prostate specific membrane antigen positron emission tomography/computed tomography and complete biochemical response after salvage lymph node dissection were significant predictors of longer therapy-free survival (all p <0.005). Prostate specific membrane antigen immunohistochemistry revealed that prostate specific membrane antigen positron emission tomography/computed tomography tends to miss small lymph node metastases <5 mm. CONCLUSIONS: Robotic salvage lymph node dissection is a feasible approach with low perioperative morbidity and delays further systemic therapy in most patients. Prostate specific membrane antigen positron emission tomography/computed tomography detection is mostly limited to tumor foci >5 mm.
引用
- Linxweiler J, Sprenk J, Cascetta K, et al. Robotic Salvage Lymph Node Dissection in Recurrent Prostate Cancer: Lessons Learned from 68 Cases and Implications for Future Clinical Management. J Urol. 2021. PMID: 33617326. doi:10.1097/JU.0000000000001697
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。